Solganick & Co.

SEPTEMBER 2, 2024

February 2024: As part of the aftershocks of Broadcom’s $69 billion acquisition of virtualization giant VMware in 2023, private equity firm KKR announced a deal to buy VMware’s End User Computing business for approximately $4 billion. per share in cash in a transaction that values the Company at approximately $1.25 billion.

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52

How2Exit

MARCH 31, 2024

This episode serves as a deep dive into Patrick's journey from a young accounting graduate to a M&A powerhouse, navigating transactions in industries as varied as HVAC and pharmaceuticals. rn Key Takeaways: rn rn rn Business valuation is often industry-specific, and the market sets the price based on comparable sales in the recent past.

Business 130

Business Mergers and Acquisitions Securities M&A 130

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. For example, the sale of Horizon Therapeutics to Amgen for approximately $28 billion was the third-largest all-cash transaction in the pharmaceutical sector in history.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Software Equity Group

JANUARY 22, 2024

Urgency Drives Healthy M&A Valuations Beyond the standard financial metrics that typically create valuations in any industry, the healthcare sector has several distinctive elements that significantly contribute to its valuation dynamics. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

Urgency Drives Healthy M&A Valuations Beyond the standard financial metrics that typically create valuations in any industry, the healthcare sector has several distinctive elements that significantly contribute to its valuation dynamics. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Growth Business

MAY 31, 2023

By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success According to research from Beauhurst , the first quarter of 2022 was the top performing equity investment quarter on record, with £7.28bn invested into UK start-ups. Investors typically invest between £250,000 and £2m in equity funding in tech start-ups.

Investment 71

Investment Investors Funds Business 71

Software Equity Group

AUGUST 20, 2024

Since its founding in 2012, the private-equity-backed company has made 69 investments. Vitec Software Vitec Software is a diversified software company that serves multiple industries, including the pharmaceutical, automotive, financial services, healthcare, real estate, and education sectors.

Investment 52

Investment Management Acquisitions Business 52

Cooley M&A

JANUARY 30, 2024

To that end, many top activists stay close to private equity firms (or even activist buyout funds) to assess targets ripe for an M&A campaign. Starboard Value and private equity sponsor Hellman & Friedman both investing in Splunk over the course of 2022, with Splunk agreeing to be acquired by Cisco in September 2023 for $28 billion.

Private Equity 52

Private Equity M&A Investors Capital 52

Cooley M&A

JANUARY 22, 2021

The second half of the year witnessed a rebound spurred by several multibillion-dollar deals, including Gilead’s acquisition of Immunomedics for nearly $21 billion and AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals for $39 billion. While deal value was down for the year, deal volume was relatively stable (down only 2.0%

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

FEBRUARY 15, 2017

After some highly anticipated IPOs in the first half of 2017, we expect the reopening of capital markets in the latter half of the year to provide more stabilized valuations for companies, which should lead to more normalcy in M&A and strategic combinations.

M&A 40

M&A IPO Pharmaceutical Valuation 40